Variable | Pregabalin ± Placebo (n = 23) | Pregabalin ± Agomelatine (n = 23) | P-value |
---|---|---|---|
Sex • Male • Female | 3 (13) 20 (87) | 13 (56.5) 10 (43.5) | 0.001 |
Age • < 30 years • 30–40 years • 40–50 years • 50–60 years | 3 (13) 4 (17.4) 5 (21.70 11 (47.8) | 5 (21.7) 4 (17.4) 2 (8.7) 12 (52.2) | 0.89 |
Disease duration • < 1 month • 1–12 months • > 12 months | 1 (4.3) 8 (34.8) 14 (60.9) | 2 (8.7) 6 (26.1) 15 (65.2) | 0.91 |
Education • Undergraduate • Bachelor • Master • Doctorate | 15 (65.2) 6 (26.1) 1 (4.3) 1 (4.3) | 15 (65.2) 8 (34.8) 0 0 | 0.9 |
Medicine taking • Regular • Irregular | 22 (95.7) 1 (4.3) | 23 (100) 0 | 0.96 |
Employment status • Employed • Unemployed | 4 (17.4) 19 (82.6) | 11 (47.8) 12 (52.2) | 0.013 |
Marriage status • Single • Married | 4 (17.4) 19 (82.6) | 5 (21.7) 18 (78.3) | 0.88 |
Body mass index • > 24.9 Kg/m2 • 18.5–24.9 Kg/m2 • < 18.5Kg/m2 | 13 (56.5) 9 (39.1) 1 (4.3) | 14 (60.9) 8 (34.8) 1 (4.3) | 0.93 |
Smoking status • Smoker • Non-smoker | 3 (13) 20 (87) | 4 (17.4) 19 (82.6) | 0.95 |
Physical activity • Yes • No | 21 (91.3) 4 (8.7) | 21 (91.3) 2 (8.7) | - |
Family history of CLBP* • Yes • No | 13 (56.5) 10 (43.5) | 15 (65.2) 8 (34.8) | 0.79 |